HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cells

International Journal of Cancer

Volumn 83, Issue 5, 1999, Pages 640-649

  Beviglia, Lucia ^a,b   Kramer, Randall H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; FOCAL ADHESION KINASE; LAMININ; SCATTER FACTOR; TYROSINE KINASE RECEPTOR;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CARCINOMA CELL; CELL ADHESION; CELL MOTILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANTIBODIES; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HEPATOCYTE GROWTH FACTOR; INTEGRINS; LAMININ; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RATS; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0032735443     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991126)83:5<640::AID-IJC13>3.0.CO;2-D     Document Type: Article

References (21)

1. ABEDI, H. and ZACHARY, I., Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. biol. Chem., 272, 15442-15451 (1997).
2. BEVIGLIA, L., MATSUMOTO, K., LIN, C.S., ZIOBER, B. and KRAMER, R.M., Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int. J. Cancer, 74, 301-309 (1997).
3. FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J. cell Biol., 119, 893-903 (1992).
4. CHEN, H.C., CHAN, P.C., TANG, M.J., CHENG, C.H. and CHANG, T.J., Tyrosine phosphorylation of focal adhesion kinase stimulated by hepatocyte growth factor leads to mitogen-activated protein kinase activation. J. biol. Chem., 273, 25777-25782 (1998).
5. GIANCOTTI, F.G., STEPP, M.A., SUZUKI, S., ENGVALL, E., and RUOSLAHTI, E., Proteolytic processing of endogenous and recombinant beta 4 integrin subunit. J. cell Biol., 118, 951-959 (1992).
6. GILMORE, A.P., and ROMER, L.H., Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol. Biol. Cell., 7, 1209-1224 (1996).
7. HATAI, M., HASHI, H., MOGI, A., SOGA, H., YOKOTA, J., and YAOI, Y., Stimulation of tyrosine-and serine-phosphorylation of focal adhesion kinase in mouse 3T3 cells by fibronectin and fibroblast growth factor. FEBS Lett., 350, 113-116 (1994).
8. HYNES, R.O., Integrins: versatility, modulation and signaling in cell adhesion. Cell. 69, 11-25 (1992).
9. ILIC, D., FURUTA, Y., KANAZAWA, S., TAKEDA, N., SOBUE, K., NAKATSUJI, N., NOMURA, S., FUJIMOTO, J., OKADA, M., YAMAMOTO, T. and ALZAWA, S., Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature (Lond.), 377, 539-544 (1995).
10. JIANG, W., HISCOX, S., MATSUMOTO, K., and NAKAMURA, T., HGF/SF, its molecular, cellular, and clinical implications in cancer. Crit. Rev. Oncol. Hematol., 29, 209-248 (1999).
11. LICHENER, R.B., WIEDEMUTH, M., CHRISTINE, N.J., and SCHIRMACHER, V., Rapid effects of EGF on cytoskeletal structures and adhesive properties of highly metastatic rat mammary adenocarcinoma cells. Clin. exp. Metastasis, 11, 113-125 (1993).
12. MATSUMOTO, K., MATSUMOTO K., NAKAMURA, T. and KRAMER, R.H., Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous carcinoma cells. J. biol. Chem., 269, 31807-31813 (1994).
13. FAK) in invasive tumors. Cancer Res., 55, 2752-2755 (1995).
14. FAK. Nature (Lond.), 380, 358-340 (1996).
15. STETLER-STEVENSON, W.C., AZNAVOORIAN, S., and LIOTTA, L.A., Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann. Rev. Cell Biol., 9, 541-573 (1993).
16. TAJIMA, H., MATSUMOTO, K. and NAKAMURA, T., Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines. FEBS Lett., 291, 229-232 (1991).
17. TUCK, A.B., PARK, M., STERN, E.E., BOAG, A. and ELLIOTT, B.E., Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Amer. J. Pathol., 148, 225-232 (1996).
18. WEIMAR, I.S., DE JONG, D., MULLER, E.J., NAKAMURA, T., VAN GORP, J.M., DE GAST, G.C. and GERRITSEN, W.R., Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix via α4β1 and α5β1 integrins. Blood, 89, 990-1000 (1997).
19. XU, L., YANG, X., CRAVEN, R.J., and CANCE, W.G., The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth Differentiation, 9, 999-1005 (1998).
20. YAMADA, K. and GEIGER, B., Molecular interactions in cell adhesion complexes. Curr. Opinion cell Biol., 9, 76-85 (1997).
21. YAMASHITA, J., OGAWA, M., YAMASHITA, S., NOMURA, K., KURAMOTO, M., SAISHOJI, T., and SHIN, S., Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res., 54, 1630-1633 (1994).